Navigation Links
Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
Date:2/20/2008

, electron and respiratory-gated treatments.

"No other company offers this level of options for customizing treatments according to each patient's specific needs on one treatment machine. Doctors can utilize the advances of RapidArc for prostate and head and neck treatments, and still offer world-class fixed beam IMRT treatments with motion management for lung and breast tumors and electron treatments for patients with superficial lesions."

The first symposium has already taken place in Dallas, Texas and future events are scheduled for Orlando, FL. (February 28th); Newport Beach, CA. (March 18th); Chicago, IL. (May 3rd); Boston, MA.(May 7th); Philadelphia, PA. (June 12th); and Toronto, Canada (date tbc). External speakers have included Dr. Karl Otto, PhD, British Columbia Cancer Agency, Vancouver and Dr. Cedric Yu, ScD, University of Maryland Medical Center, Baltimore, MD. These symposia are intended exclusively for medical professionals.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X- ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,600 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

Forward Looking Statements

Statements in this press release regarding future business, event
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...onal Pediatric AIDS Initiative Will Improve... WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- Th... government, Baylor College of Medicine, the,gover...S. President,s,Emergency Plan for AIDS Relief (PEP... improve care and treatment for children with HIV/...
(Date:8/29/2008).../ -- Conseco Insurance Company, a life,and health ...y of its new,indexed universal life insurance pro...de potential with downside protection., ConsecoLi... offers the,opportunity for long-term cash buildup...ents can customize their coverage levels with eigh...
(Date:8/29/2008)...SNewswire/ -- The U.S. Department of,Labor propose...public to,see exactly what goes into agency risk a...r http://edocket.access.gpo.gov/2008/E8-20179.htm...st available evidence and,scientific data are used...ards regulating occupational exposure to toxins in...
(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
Breaking Medicine News(10 mins):Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 2Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 3Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 4Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...that the magnets that are sold in the market does ...t health problems//. Magnet that are advertised ov...ot posses any theoretical and experimental value. ...ful athletes mainly to relive pain but the researc...
...lized medicine, one should reevaluate new medicine...ry//, Ph.D., Dr. Berry, professor and chair of t...tics at The University of Texas M. D. Anderson Can...linical trials are designed and conducted in the U...
... Woodruff (R) said he had filed a bill (HB 1096) t...s delivering the baby// would endanger the life or... law to make performing an abortion a Class C felo...ar prison sentence. Woodruff said he introduced t...
...o have late children but fear loss in fertility ca...and can use it when they want their children.// Th...ertility to store their embryo without fear of loo...ll be very useful for cancer patients who are plan...
Other Medicine News:Health News:Does Magnet Therapy Posses Healing Powers? 2Health News:New Generation Clinical Trials Could Save Time And Money, Improve Patient Care 2
(Date:8/26/2008)...DIANAPOLIS, Aug. 26 /- Semafore Pharm...rnational Congress on Targeted Therapies,in Cancer...novel,multi-targeted kinase inhibitors that demons...al studies., A novel and proprietary molecular sc...ling allowing for the design of pan-PI3 kinase inh...
(Date:8/26/2008)...BURN, Mass., Aug. 26 /- Cambridge Res...release of the Maestro(TM) EX In,Vivo Imaging Syst...-art,FLEX technology and becomes the entry-level i...ng., (Photo: http://www.newscom.com/cgi-bin/prnh...a significant advancement of CRi,s unique,solid-st...
(Date:8/26/2008)...ATTLE, Aug. 26 /- Omeros Corporation ...m a Phase 1/Phase 2 trial investigating,OMS103HP i...construction,surgery. OMS103HP is an investigation...gation solution and is designed to improve postope...ive pain and allow patients an,earlier return to w...
(Date:8/25/2008)...LLESLEY HILLS, Mass., Aug. 25 /- Jose...assets of Spherics, Inc. ("Spherics") for,the bene...eutical,intellectual property will be sold at a se... an extended release formulation of Levodopa-Carbi...or Parkinson,s disease, with global,sales estimate...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss 2866 1Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss 2866 2Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss 2866 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 7263 1NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 7263 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 7263 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 7263 4TVM Capital Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 7260 1TVM Capital Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 7260 2TVM Capital Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 7260 3TVM Capital Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 7260 4TVM Capital Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 7260 5Creating unconventional metals 7259 1Creating unconventional metals 7259 2
...nt Therapy Significantly,Improved Absorption of Fa... and DAYTON, Ohio, April 04, 2007 /PRNewswire/ --,... today unveiled,data from two phase III clinical t...formerly EUR-1008, for the treatment of,Exocrine P...g,Administration (FDA) granted fast track status f...
...2007 - CytRx Corporation,(NASDAQ:CYTR) today annou...studies indicating that CytRx,s lead drug candidat...ry of sensory and,motor function in an experimenta...hheld as long as 48 hours after stroke was,induced...ata,announced by CytRx in December 2006. Orally-ad...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
The EZY Close post op shoe's flap-on-flap closure provides a secure fit and can accommodate even the bulkiest of dressing. Perfect for older patients with limited hand dexterity.
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure.
...for patients who experience severe plantar fasciit... fibrous tissue that can occur after rest periods ...ing. The continuous tension and fixed position red...d helps stretch the Achilles tendon to provide rel...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products: